TrialNeurology(R) neuroimmunology & neuroinflammation2021
Safety and Immune Effects of Blocking CD40 Ligand in Multiple Sclerosis.
Camilo E Fadul et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this paperpooled ittrialcites it